Patient-identifiable information cannot, in general, be shared outside the clinical care team without explicit consent [1]. Generative AI can reduce clinician burden, but it also brings risks that include privacy harms, misinformation and over-reliance on automation [2]. Removing identifiers before a case is entered into an external tool is the simplest way to reduce the privacy risk, and most clinical questions lose nothing in the process.
The legal frameworks differ by country and by purpose. The HIPAA Privacy Rule in the United States, the General Data Protection Regulation in the European Union and the United Kingdom, and the Privacy Act in Australia are examples, and each uses its own terms and definitions. Even expert recommendations on how to anonymise health data differ [3]. This article is a practical routine, not legal advice: your institution's policy, and the tools it has approved, take precedence.